XTX Topco’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
46,033
-62,959
-58% -$1.47M 0.01% 1669
2026
Q1
$1.53M Buy
+108,992
New +$1.47M 0.03% 1064
2024
Q3
Sell
-10,154
Closed -$202K 2079
2024
Q2
$202K Buy
+10,154
New +$198K 0.02% 1234
2023
Q4
Sell
-10,473
Closed -$212K 1583
2023
Q3
$212K Buy
+10,473
New +$237K 0.04% 983
2021
Q3
Sell
-8,240
Closed -$300K 683
2021
Q2
$300K Buy
8,240
+3,574
+77% +$148K 0.1% 366
2021
Q1
$204K Buy
+4,666
New +$219K 0.1% 489

Other funds holding AVNS

XTX Topco's AVNS Position: Q2 2026 in Review

XTX Topco reduced its Avanos Medical (AVNS) stake by 58% in Q2 2026, selling an estimated $1.47M and leaving 46,033 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #1669.

XTX Topco first reported a position in AVNS in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.53M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • XTX Topco held 46,033 shares of Avanos Medical worth $1.15M as of Q2 2026.
  • XTX Topco sold 62,959 Avanos Medical shares in Q2 2026, an estimated $1.47M.
  • Avanos Medical made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1669 holding.
  • XTX Topco first reported a position in Avanos Medical in Q1 2021 and has held it in 6 quarters since.
  • XTX Topco's Avanos Medical position peaked at $1.53M in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.